A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorZhujiang Hospital
About this trial
By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Eligibility criteria
Qualifiers
Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
Age: over 18 years old;
There are sufficient remaining serum samples and extensive informed consent has been signed.
Disqualifiers
Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
Improper storage or repeated freeze-thaw of remaining serum samples.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
10,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov